In addition, CMTM3 accelerates the degradation of EGFR, inhibits the EGFR/STAT3/EMT signaling pathway, increases the expression of TP53, and enhances the TP53 signaling pathway in chordoma cells (Yuan et al., 2021). The gene discussed is TP53; the disease is chordoma.